205 related articles for article (PubMed ID: 17445566)
1. In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance.
Trivedi HL; Vanikar AV; Modi PR; Shah PR; Shah VR; Trivedi VB
Transplant Proc; 2007 Apr; 39(3):653-7. PubMed ID: 17445566
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
[TBL] [Abstract][Full Text] [Related]
3. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
7. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier.
Siemionow MZ; Klimczak A; Unal S
Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547
[TBL] [Abstract][Full Text] [Related]
8. Renal transplantation in primary focal segmental glomerulosclerosis using a tolerance induction protocol.
Suthar K; Vanikar AV; Trivedi HL
Transplant Proc; 2008 May; 40(4):1108-10. PubMed ID: 18555125
[TBL] [Abstract][Full Text] [Related]
9. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
10. Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient:--a case report.
Trivedi HL; Mishra VV; Vanikar AV; Modi PR; Shah VR; Shah PR; Firoz A
Transplant Proc; 2006 Nov; 38(9):3103-8. PubMed ID: 17112910
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience.
Vanikar AV; Modi PR; Patel RD; Kanodia KV; Shah VR; Trivedi VB; Trivedi HL
Transplant Proc; 2007 Apr; 39(3):703-8. PubMed ID: 17445577
[TBL] [Abstract][Full Text] [Related]
12. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
[TBL] [Abstract][Full Text] [Related]
13. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
14. Correlation of donor leukocyte chimerism with pulmonary allograft survival after immunosuppressive drug withdrawal in a porcine model.
Kruse B; Thissen S; Warnecke G; Avsar M; Gottlieb J; Hohlfeld JM; Karstens JH; Kaever V; Länger F; Pabst B; Ungefroren H; Haverich A; Strüber M
Transplantation; 2009 May; 87(10):1468-77. PubMed ID: 19461483
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
16. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
17. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
Cosimi AB; Sachs DH; Sykes M; Kawai T
Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
[TBL] [Abstract][Full Text] [Related]
18. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.
Shields LE; Gaur L; Delio P; Potter J; Sieverkropp A; Andrews RG
Stem Cells; 2004; 22(5):759-69. PubMed ID: 15342940
[TBL] [Abstract][Full Text] [Related]
19. Operational tolerance in living-related renal transplantation: a single-center experience.
Vanikar AV; Goplani KR; Feroz A; Kanodia KV; Patel RD; Suthar KS; Patel HV; Gumber MR; Shah PR; Trivedi HL
Transplant Proc; 2011 Jun; 43(5):1551-8. PubMed ID: 21693233
[TBL] [Abstract][Full Text] [Related]
20. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
